#breaking The HIV treatment combining #islatravir and #lenacapavir achieved its primary efficacy endpoint in two phase 3 trials, bringing the investigational regimen closer to becoming the first approved long-acting oral #HIV therapy. #IDsky
www.contagionlive.com/view/once-we...
The #FDA approval of this therapy provides the first approved treatment for chronic #hepatitis delta in the US. Dr Anu Osinusi discusses how this therapy is designed to slow disease progression and improve patient outcomes. #IDsky
www.contagionlive.com/view/what-th...
[email protected] is leveraging its #phage initiative to connect researchers and clinicians, standardize approaches, and explore how phages could complement antibiotics. Dr. Colleen Kraft offers insights on ASM's plans to help grow this modality. #asmmicrobe2026 #IDsky
www.contagionlive.com/view/asm-ini...
Meta-analysis finds approximately 1% of well-appearing outpatient infants aged 60 to 90 days with fever have an invasive bacterial infection. #IDsky #Medsky
www.contagionlive.com/view/when-fe...
[email protected] dosed the first participants in LIBERTY, a phase 3 clinical trial evaluating the safety and tolerability of VYD2311, its investigational monoclonal antibody candidate for #COVID-19 prevention. #IDsky #Medsky
www.contagionlive.com/view/invivyd...
Good morning from #ASMMicrobe2026! Look for our coverage over the coming days, and if you see us onsite, please stop by to say hello!
Day 2 in DC! We are conducting more interviews at #ASMmicrobe2026! We are on the second level. Stop by to say hello if you are nearby!
In our latest podcast, Dr. Nico Michel discusses the cobas MPX-E, a new multiplex blood-screening assay streamlining transfusion safety by enabling simultaneous detection and discrimination of #HIV, #HBV, #HCV, and hepatitis E in a single test.
www.contagionlive.com/view/from-pa...
Kelly Oakeson, PhD, explains how Utah public health officials are leveraging a statewide wastewater surveillance system to monitor #measles activity, identify emerging outbreaks, and supplement traditional case reporting. #asmmicrobe2026
www.contagionlive.com/view/wastewa...
[email protected] CEO Dr. Stefano Bertuzzi discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration across disciplines and improving member engagement. #asmmicrobe2026
www.contagionlive.com/view/asm-mic...
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Contagion®
Invivyd has dosed the first participants in LIBERTY, a phase 3 trial comparing VYD2311 to an mRNA COVID vaccine and coadministration, as the BLA-enabling DECLARATION trial completes enrollment.
Meta-analysis finds approximately 1% of well-appearing outpatient infants aged 60 to 90 days with fever have an invasive bacterial infection.
www.contagionlive.com
The FDA's accelerated approval of this therapy provides the first approved treatment option for chronic hepatitis delta in the US. Anu Osinusi, MD, discusses how this targeted therapy is designed to s...
www.contagionlive.com
The American Society for Microbiology (ASM) is leveraging its new phage therapy coordination efforts to connect researchers and clinicians, standardize approaches, and explore how bacteriophages could...
A once-weekly oral HIV treatment combining islatravir and lenacapavir achieved its primary efficacy endpoint in two Phase 3 trials, bringing the investigational regimen closer to becoming the first ap...
Kelly Oakeson, PhD, explains how Utah public health officials are leveraging a statewide wastewater surveillance system to monitor measles activity, identify emerging outbreaks, and supplement traditi...
American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, discusses how they are reorganizing its structure to create more focused scientific divisions while maintaining collaboration ac...
A new multiplex blood-screening assay is streamlining transfusion safety by enabling simultaneous detection and discrimination of HIV, HBV, HCV, and hepatitis E in a single test, helping laboratories ...
